Lake Street Advisors Group’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

Lake Street Advisors Group’s Portfolio CNCE Stock Details CNCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-35,398	Closed	-$207K	–	366
2022 Q4	$207K	Hold	35,398	–	–	0.01%	218
2022 Q3	$237K	Hold	35,398	–	–	0.02%	221
2022 Q2	$149K	Hold	35,398	–	–	0.01%	201
2022 Q1	$119K	Hold	35,398	–	–	0.01%	211
2021 Q4	$112K	Hold	35,398	–	–	0.01%	204
2021 Q3	$116K	Buy	+35,398	New	+$124K	0.01%	161

Lake Street Advisors Group's CNCE Position: Q1 2023 in Review

Lake Street Advisors Group sold out of Concert Pharmaceuticals, Inc. (CNCE) in Q1 2023, closing a stake of 35,398 shares — an estimated $207K sold.

Lake Street Advisors Group first reported a position in CNCE in Q3 2021 and held it in 6 quarters. The position peaked at $237K in Q3 2022. 0 funds tracked by Wall St. Rank hold CNCE as of Q1 2023.

Lake Street Advisors Group reported no remaining Concert Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
Lake Street Advisors Group sold 35,398 Concert Pharmaceuticals, Inc. shares in Q1 2023, an estimated $207K.
Lake Street Advisors Group first reported a position in Concert Pharmaceuticals, Inc. in Q3 2021 and held it in 6 quarters.
Lake Street Advisors Group's Concert Pharmaceuticals, Inc. position peaked at $237K in Q3 2022.
0 funds tracked by Wall St. Rank held Concert Pharmaceuticals, Inc. as of Q1 2023.

Based on Lake Street Advisors Group's 13F filing for Q1 2023, filed 15 May 2023.